Literature DB >> 16221052

Cutaneous malignant melanoma: facts about sunbeds and sunscreen.

Philippe Autier1.   

Abstract

The incidence of cutaneous malignant melanoma is still increasing in most light-skinned populations. Sunscreen use has been proposed for the primary prevention of melanoma. However, sunscreen use may increase time spent in the sun when users are willing to acquire a tan or to stay in the sun for a long time, which may increase melanoma risk. When sun exposure is not associated with the desire to acquire a tan or stay in the sun for a long time, sunscreen use may prevent squamous cell skin carcinoma. Sun protection should give priority to clothing and sun exposure reduction. Over the last 20 years, tan acquisition through exposure to artificial sources of ultraviolet radiation has become frequent among fair-skinned adolescents and young adults. There is accumulating evidence that sunbed use is associated with melanoma when started before approximately 30 years of age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221052     DOI: 10.1586/14737140.5.5.821

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  3 in total

1.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

2.  A simple intervention to reinforce awareness of tanning bed use and skin cancer in non-medical skin care professionals in Southern California.

Authors:  Angie T Ng; Anne Lynn S Chang; Myles Cockburn; David H Peng
Journal:  Int J Dermatol       Date:  2012-11       Impact factor: 2.736

3.  The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice.

Authors:  Mette Mogensen; Gregor Be Jemec
Journal:  Cancer Manag Res       Date:  2010-10-28       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.